Ignite Creation Date:
2024-05-06 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 12:45 PM
Study NCT ID:
NCT03512314
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-08
First Post:
2018-04-09
Brief Title:
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension
Sponsor:
AB2 Bio Ltd
Organization:
AB2 Bio Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-05-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-04-09
First Submit QC Date:
April 19 2018
Study First Post Date:
2018-04-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-30
Last Update Post Date:
2023-11-08
Last Update Post Date Type:
ACTUAL